Details for Patent: 8,226,971

Which drugs does patent 8,226,971 protect, and when does it expire?

Patent 8,226,971 protects ZURAGARD and is included in one NDA.

This patent has twenty-four patent family members in twenty-one countries.

Summary for Patent: 8,226,971

Title:	Catheter lock solution comprising citrate and a paraben
Abstract:	This invention relates to compositions, methods, devices and kits relating to the infusion of a catheter lock solution into an indwelling catheter. Inventive compositions, methods, devices and kits aid in diminishing the effects of microbial infection in catheters and occlusion of the catheters. A lock solution provided by the invention includes citrate and a paraben. The solution preferably has a density suitable for retention of the solution in a catheter during the lock period. Another lock solution provided by the invention includes citrate, a paraben and a photo-oxidant, such as, for example, methylene blue.
Inventor(s):	Ash; Stephen R. (Lafayette, IN), Steczko; Janusz (West Lafayette, IN), Swanson; Gary L. (Elkhorn, WI)
Assignee:	Ash Access Technology, Inc. (West Lafayette, IN)
Application Number:	12/792,286
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 8,226,971

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Zurex Pharma	ZURAGARD	isopropyl alcohol	SOLUTION;TOPICAL	210872-001	Apr 26, 2019		OTC	Yes	Yes			Y

International Family Members for US Patent 8,226,971

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E453415
Australia	2006212946
Brazil	PI0606969